CRISPR Therapeutics

Vertex Readies for exa-cel Launch, Cautiously Eyes Enormous Opportunity

Vertex Gears Up for exa-cel Launch, Acknowledges Vast Opportunity with Cautious Outlook

Anika Sharma

After a prolonged journey in development, the first CRISPR-based gene editing therapy has recently received approval from an FDA advisory ...

Groundbreaking CRISPR Therapy Gets FDA Panel Nod

FDA Panel Approves First CRISPR Therapy After Rigorous Safety Evaluations

Anika Sharma

The FDA advisory committee has expressed satisfaction with the evaluation of potential off-target effects conducted by CRISPR Therapeutics and Vertex ...

CRISPR-Vertex’s gene editing therapy faces FDA committee review

CRISPR-Vertex’s gene editing therapy faces FDA committee review

Anika Sharma

A significant milestone in the pharmaceutical industry is on the horizon as an FDA advisory committee prepares to review the ...